Kenneth Leslie Powell
Plus aucun poste en cours
Profil
Kenneth Leslie Powell is the founder of Arrow Therapeutics Ltd.
and Galapagos Biotech Ltd.
founded in 1998.
Mr. Powell is also the founder of Ark Therapeutics Group Plc.
He held former positions as Non Executive Chairman at Altimmune UK Ltd., Executive Chairman at Midatech Pharma (Wales) Ltd.
from 2012 to 2014, and Head-Antiviral Research at Wellcome Foundation Ltd.
He was also a Professor at the University of California, Los Angeles from 1996 to 2000.
Anciens postes connus de Kenneth Leslie Powell
| Sociétés | Poste | Fin |
|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | 01/01/2000 |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Fondateur | - |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Fondateur | - |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Président | - |
Midatech Pharma (Wales) Ltd.
 Midatech Pharma (Wales) Ltd. Pharmaceuticals: MajorHealth Technology Midatech Pharma (Wales) Ltd. develops advanced life science and therapeutic products. The company was founded on October 10, 2003 and is headquartered in Cardiff, the United Kingdom. | President | 12/12/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
| Wellcome Foundation Ltd | Commercial Services |
Midatech Pharma (Wales) Ltd.
Midatech Pharma (Wales) Ltd. Pharmaceuticals: MajorHealth Technology Midatech Pharma (Wales) Ltd. develops advanced life science and therapeutic products. The company was founded on October 10, 2003 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Health Technology |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
